Liraglutide Research
Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis
Diabetes, Obesity & Metabolism·February 1, 2026
Valeria Gutierrez de Piñeres, Claudia S. Tamayo-Torres, Arantxa Ramirez-Cisneros, Marianthi Kavelidou, Konstantinos Stefanakis, Christos S. Mantzoros
Summary
Investigated short-term effects of liraglutide on metabolic parameters, detailed body composition, and myostatin-activin-follistatin-IGF-1 axis components.
Study Details
Study Design
Randomized, double-blind, placebo-controlled crossover trial
Indication
Type 2 diabetes mellitus
Intervention
Liraglutide up to 1.8 mg/day for 18 days
Species
Human
Sample Size
20 subjects